[Hopespringpcsg] FW: Canadian Cancer Survivor Network Prostate Patient Questionnaire - Enzalutamide (Xtandi)

[Glen Tolhurst]

Hi all:

If you have taken XTANDI /Enzalutamide, you may wish to  take the survey shown below.

Thx.

Glen

 

From: CCSN Communications [mailto:communications at survivornet.ca] 
Sent: September 27, 2018 11:59 AM
To: glen.tolhurst at sympatico.ca
Subject: Re: Canadian Cancer Survivor Network Prostate Patient Questionnaire - Enzalutamide (Xtandi)

 

Hello Glen,

 

This is just a reminder to let you know that our prostate cancer patient questionnaire for Enzalutamide (Xtandi) ends this Monday, October 1st! 

 

To complete the survey, click here. <https://www.surveymonkey.com/r/72VYGWC> 

 

Thanks for your assistance with the distribution of this survey! Have a great weekend.

 

Best,

Allison

 

On Wed, Sep 12, 2018 at 3:01 PM CCSN Communications <communications at survivornet.ca> wrote:

Hello Glen, I hope you're doing well!

My name is Allison MacAlister, and I'm the Communications Coordinator for the Canadian Cancer Survivor Network. I'm writing you today to let you know about a survey we're conducting in order to complete an informed patient evidence submission for a new medication for prostate cancer. 

The survey is intended for patients with either metastatic or non-metastatic castration-resistant prostate cancer (CRPC) and their caregivers. 

The survey information and link are below. We would greatly appreciate it if you would share the link to this survey with your networks, as we are gathering as many responses as possible across Canada. If you have any questions, please don't hesitate to contact me.

Thank you for your time!

Cheers,
- Allison

-------------------------------------------------

ARE YOU A CANADIAN PROSTATE CANCER PATIENT OR CAREGIVER_ (1).png

The purpose of the survey is to provide the Canadian Cancer Survivor Network (CCSN) with insights and perspectives about living with and managing castrate resistant prostate cancer (CRPC) from patients and caregivers in order to complete a patient evidence submission for a new medication for non-metastatic castration-resistant prostate cancer called Enzalutamide (Xtandi). 

We are looking for input from patients with both metastatic or non-metastatic castration-resistant prostate cancer (mCRPC) and their caregivers. The purpose of this survey is to understand the experience with Enzalutamide (Xtandi) or the need for Enzalutamide to prolong progression from non-metastatic to metastastic disease. If you are a patient outside of this specification and feel you may also benefit from this treatment, we would like to hear from you as well.

The pan-Canadian Oncology Drug Review invites patient groups like CCSN to prepare and send in submissions so that patients and caregivers like you can be heard. Please join us and have your voice included in this important submission process.

The survey only takes about ten minutes to complete, and will remain open until October 3rd, 2018.



Click here to take the survey! <https://www.surveymonkey.com/r/72VYGWC> 

 

-- 

Allison MacAlister

Communications and Social Media Coordinator

Coordonnatrice, Communications et médias sociaux

Canadian Cancer Survivor Network

Réseau canadien des survivants du cancer

1750 croissant Courtwood Crescent, Suite 210

Ottawa, ON K2C 2B5

Telephone / Téléphone :  <tel:613-898-1871> 613-898-1871

E-mail / Courriel : communications <mailto:communications at survivornet.ca> @survivornet.ca

Web site / site web:  <http://www.survivornet.ca/> www.survivornet.ca

Twitter: @ <http://www.twitter.com/survivornetca> survivornetca
------------------------------------------------------------

  <https://docs.google.com/uc?export=download&id=1_TTnbuXZhZCWbEl8_rhbND37fzJFvODV&revid=0B5ATa4dYsL_LTVlWcktEdm5PRWw5NDl6UklZbEhxeHVRK1hZPQ> 

Register now for our next free webinar! <https://register.gotowebinar.com/register/9030239914313835267>  Liver Cancer 101: Causes, Treatments, Innovations & Access




 

-- 

Allison MacAlister

Communications and Social Media Coordinator

Coordonnatrice, Communications et médias sociaux

Canadian Cancer Survivor Network

Réseau canadien des survivants du cancer

1750 croissant Courtwood Crescent, Suite 210

Ottawa, ON K2C 2B5

Telephone / Téléphone :  <tel:613-898-1871> 613-898-1871

E-mail / Courriel : communications <mailto:communications at survivornet.ca> @survivornet.ca

Web site / site web:  <http://www.survivornet.ca/> www.survivornet.ca

Twitter: @ <http://www.twitter.com/survivornetca> survivornetca
------------------------------------------------------------

 <https://register.gotowebinar.com/register/9030239914313835267> 

 <https://register.gotowebinar.com/register/9030239914313835267> Register now for our next free webinar! Liver Cancer 101: Causes, Treatments, Innovations & Access

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://artsservices.uwaterloo.ca/pipermail/hopespringpcsg/attachments/20180928/ccdb8dcc/attachment-0001.html>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image001.png
Type: image/png
Size: 69798 bytes
Desc: not available
URL: <http://artsservices.uwaterloo.ca/pipermail/hopespringpcsg/attachments/20180928/ccdb8dcc/attachment-0001.png>